InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Mr Stockboy Free
03/18/24 6:38 PM
Bullish
Bullish
profile icon
north40000 PremiumMember
03/18/24 5:47 PM
profile icon
Tatsumaki Free
03/18/24 4:24 PM
profile icon
north40000 PremiumMember
03/18/24 4:10 PM
profile icon
Tatsumaki Free
03/18/24 3:57 PM
profile icon
Bolio98 Free
03/18/24 3:50 PM
profile icon
north40000 PremiumMember
03/18/24 3:32 PM
profile icon
JRoon71 PremiumMember
03/18/24 3:30 PM
profile icon
ORBAPU Free
03/18/24 3:24 PM
profile icon
ilovetech PremiumMember
03/18/24 3:12 PM
profile icon
JRoon71 PremiumMember
03/18/24 2:48 PM
profile icon
ORBAPU Free
03/18/24 2:43 PM
profile icon
ramfan60 Free
03/18/24 2:41 PM
profile icon
JRoon71 PremiumMember
03/18/24 2:21 PM
profile icon
ORBAPU Free
03/18/24 2:18 PM
profile icon
Tatsumaki Free
03/18/24 2:13 PM
profile icon
north40000 PremiumMember
03/18/24 1:51 PM
profile icon
north40000 PremiumMember
03/18/24 1:13 PM
profile icon
north40000 PremiumMember
03/18/24 12:42 PM
profile icon
DMC8 Free
03/18/24 12:38 PM
Bullish
Bullish
profile icon
north40000 PremiumMember
03/18/24 12:29 PM
profile icon
ilovetech PremiumMember
03/18/24 11:52 AM
profile icon
north40000 PremiumMember
03/18/24 11:47 AM
profile icon
JRoon71 PremiumMember
03/18/24 11:31 AM
profile icon
JRoon71 PremiumMember
03/18/24 11:03 AM
profile icon
the_kube Free
03/18/24 11:00 AM
profile icon
ziploc_1 Free
03/18/24 10:06 AM
profile icon
JRoon71 PremiumMember
03/18/24 9:42 AM
profile icon
Giovinco Free
03/18/24 9:09 AM
profile icon
ziploc_1 Free
03/18/24 8:55 AM
profile icon
dogn Free
03/17/24 11:57 PM
profile icon
dogn Free
03/17/24 11:29 PM
profile icon
dogn Free
03/17/24 11:29 PM
profile icon
north40000 PremiumMember
03/17/24 10:52 PM
profile icon
north40000 PremiumMember
03/17/24 10:41 PM
profile icon
dogn Free
03/17/24 10:31 PM
profile icon
ilovetech PremiumMember
03/17/24 9:00 PM
profile icon
north40000 PremiumMember
03/17/24 6:30 PM
profile icon
north40000 PremiumMember
03/17/24 4:50 PM
profile icon
north40000 PremiumMember
03/17/24 3:27 PM
profile icon
seve333 Free
03/17/24 3:16 PM
profile icon
CaptBeer Free
03/17/24 1:10 PM
profile icon
ilovetech PremiumMember
03/17/24 11:50 AM
profile icon
dogn Free
03/17/24 11:36 AM
profile icon
north40000 PremiumMember
03/17/24 11:30 AM
profile icon
Giovinco Free
03/17/24 11:22 AM
profile icon
CaptBeer Free
03/17/24 9:06 AM
profile icon
Bolio98 Free
03/17/24 6:07 AM

Amarin Corp Plc (AMRN) RSS Feed

Followers
1105
Posters
Posts (Today)
30
Posts (Total)
422337
Created
03/12/07
Type
Free
Moderators ziploc_1 zmanindc golf stud tm100 Number sleven

AMARIN TICKER RELATED LINKS
Amarin Webpage
NASDAQ AMRN Quote 
Y! Finance AMRN Landing Page 
Seeking Alpha AMRN Landing Page
FinViz AMRN Landing Page


VASCEPA RELATED LINKS & Outside Organizational News
The EPA Drug Initiative (EPADI)
Vascepa Savings Card Program
FDA Orange Book entry for Vascepa
Vascepa Prescribing Information
Vascepa Marine DTC Patient Brochure
Nissui EPA Synthesis History & Methodology
FDA Approval of Vascepa for the Reduction of Triglyceride Levels ≥ 500mg/dL (26 Jul 2012)
Pure EPA Vascepa Now Available in Half-Gram Capsule Size (25 Oct 2016)
ADA’s 2019 Standards of Medical Care in Diabetes Incorporate Findings from REDUCE-IT (28 Mar 2019)
New 2019 Updates to the European Society of Cardiology and European Atherosclerosis Society’s Guidelines incorporate Reduce-IT (3 Sep 2019)
National Lipid Association’s New Position Statement on Use of Icosapent Ethyl (16 Sep 2019)
Independent Drug-Pricing Assessment Finds Vascepa Cost-Effective (17 Oct 2019)

RELEVANT SOCIAL MEDIA ACCOUNTS
Amarin Instagram - @amarincorp Amarin Twitter - @amarincorp Amarin LinkedIn Amarin ADP Portal - Job Openings Dr. Bhatt Twitter - @DLBHATTMD
TerraPharma Twitter - @TerraPharma1 John Cappello Twitter - @JohnCappello RafunRafun Twitter - @ra_fun K Trivedi Twitter - @GPUWorld  
 

VASCEPA CLINICAL TRIALS + FDA Meetings
Marine & Anchor (Amarin Led)
MARINE Study meets primary endpoints(29 Nov 2010)
ANCHOR Trial meets all Primary and Secondary Endpoints (18 Apr 2011)
Additional Inflammatory Marker Data from Marine and Anchor (22 Jan 2013)
New Clinical Data Showing Significant Reductions in Apolipoprotein C-III Levels in Marine and Anchor (8 April 2013)
FDA AD-Com Outcome for Anchor sNDA (16 October 2013)
FDA delays ANCHOR sNDA (20 Dec 2013)
Presentation of MARINE and ANCHOR analyses at AHA showing significant reduction of remnant-like particle cholesterol (17 Nov 2014)
Marine & Anchor Key Summaries (2017)
Vascepa showed reductions in potentially atherogenic lipids and inflammatory markers – Anchor post-hoc (12 Mar 2018)

REDUCE-IT (Amarin Led)
NIH Clinical Trial Page
Amarin Announces Dosing of First Patient in REDUCE-IT (7 Dec 2011)
Amarin and FDA Reaffirm Concurrence on REDUCE-IT through SPA Agreement Amendment (4 Aug 2016)
Amarin Randomizes Final Patient into REDUCE-IT (31 Aug 2016)
REDUCE-IT to Continue As Planned at Recommendation of Independent Data Monitoring Committee (14 Aug 2017)
REDUCE-IT Meets Primary Endpoint (24 Sep 2018)
REDUCE-IT Displayed 25% RRR in 5-Point MACE (10 Nov 2018)
REDUCE-IT NEJM Article(3 Jan 2019)
REDUCE-IT showed 30% reduction in total Cardiovascular events (18 Mar 2019)
Amarin submits sNDA seeking new indication based on REDUCE-IT (28 Mar 2019)
FDA Grants Priority Review for Vascepa sNDA (29 May 2019)
Amarin Notified of Ad-Com Meeting Planned for Nov 2019 (8 Aug 2019)
REDUCE-IT USA-specific Results released (11 Nov 2019)
FDA AD-Com Outcome for REDUCE-IT sNDA (14 Nov 2019)
REDUCE-IT related data presented at 2019 AHA (18 Nov 2019)


PARTNERSHIPS / OVERSEAS
Amarin and Eddingpharm announce agreement for Vascepa in China (26 Feb 2015)
Amarin and HLS announce agreement for Vascepa in Canada (25 Sep 2017)
Commencement of Vascepa Clinical Development in China (17 Jan 2018)
Biologix and Amarin announce approval of Vascepa in Lebanon for patients with Triglyceride Levels ≥ 500mg/dL (21 Mar 2018)
Amarin & Mochida Announce Collaboration on Future Development of EPA-Based Drug Products and Indications (12 Jun 2018)
Biologix and Amarin announce approval of Vascepa in UAE for patients with Triglyceride Levels ≥ 500mg/dL (26 Jul 2018)
Vascepa granted Priority Review from Health Canada New Drug Submission, anticipated to be filed in April 2019 by HLS (29 Mar 2019)
HLS files New Drug Submission for Vascepa with Health Canada (29 April 2019)


EPA Trials for other indications
Section Pending

Non-Vascepa (AMR-101) Amarin Trials
Section Pending

 

Top Posts With Reactions
(Last 30 Days)
profile-icon
north40000 02/26/24 7:22 PM
👍️
🤑
12
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
New Post